Pacific Bridge Medical - China Medical Publications
China Pharmaceutical Market Report 2008
Published by Pacific Bridge Medical	Print Article
By Ames Gross and John Minot	2008

Price: $500

Overview:

China’s pharmaceutical market is not only large and growing quickly – at almost 20% in 2007 – in the near future, it will also join the world’s biggest pharmaceutical markets. This makes it strategically crucial for Western pharmaceutical companies to succeed there. However, the Chinese drug market has unique characteristics which must be understood to make the China potential a reality.

This research report contains key information on multiple important topics of the Chinese pharmaceutical market, including market data, the role of government health insurance reimbursement, government price controls, institutional purchasing practices, differing characteristics and business strategies of domestic and foreign pharmaceutical companies, and more. It also includes two appendices, one on recent acquisitions, ventures, and partnerships in the Chinese drug industry, and the other listing all drugs which Chinese government health insurance will reimburse.

This report is 34 pages. The appendices are an additional 22 pages.

Click here to view a sample page of this report.

Table of Contents

I. Introduction to China

II. Overview of China Drug Market

i. Growth in Healthcare Spending
ii. Pharmaceutical Sales

III. Health Insurance in China

i. Overview
ii. Basic Medical Insurance
iii. Other Public Health Insurance Systems
iv. Private Health Insurance

IV. Drug Reimbursement System

i. Mechanics of Drug Reimbursement
ii. Drug Reimbursement List
iii. Who Controls Revisions to Drug Reimbursement Lists
iv. When Reimbursement is Important
v. Strategies for Reimbursement List Entry

V. Price Determination

VI. Hospital Purchasing and Prescribing

i. Hospital Tendering
ii. Prescription Controls

VII. Foreign Pharmaceutical Companies in China

i. Overview
ii. Trends

VIII. Domestic Chinese Pharmaceutical Companies

i. Overview
ii. Domestic Pharmaceutical Companies’ Changing Strategies

IX. Pharmaceutical Distribution in China

X. Predicted Trends

i. Overview
ii. Healthcare Providers
iii. Healthcare Funding
iv. Reimbursement System
v. Price Determination
vi. Regulatory Approvals

XI. Conclusion

Appendices:

Appendix A: Recent Acquisitions, Ventures, and Partnerships in the Chinese Drug Industry
Appendix B: National Reimbursement Drug List

Order now and we will ship you this report at NO ADDITIONAL CHARGE.

Price:
$500 Report

Contact us at researchstore@pacificbridgemedical.com if you have any questions. 

Read more >> Publications Index

Go to Home